Introduction: Fish milt is currently used predominantly as a culinary product, despite containing numerous biologically active compounds with high value-added potential, including nucleoproteins, enzymes, and proteins. Its integrated processing creates an opportunity to recover biologically valuable compounds, including DNA and hyaluronidase, within a single technological cycle. Objective: To develop an integrated technology for the processing of fish milt with the sequential recovery of DNA and hyaluronidase while preserving their target properties. Materials and Methods: Frozen fish milt was mechanically homogenized and extracted at reduced temperature with acetic acid using a raw material-to-extractant ratio of 1:2. Following centrifugation, the soluble fraction containing hyaluronidase was clarified and concentrated by ultrafiltration. The precipitate containing the DNA–protein complex was hydrolyzed with trypsin at a water-to-precipitate-to-trypsin ratio of 2:1:0.3 and subsequently centrifuged to isolate the DNA fraction. Hyaluronidase activity was determined using a pharmacopeial method. The enzyme-containing fraction was additionally characterized by Fourier-transform infrared spectroscopy. DNA quality was assessed by spectrophotometry; residual protein in the DNA fraction was quantified using the micro-biuret method, and the preparation was additionally characterized by infrared spectroscopy. The yields of DNA and the hyaluronidase-containing fraction were determined using a rapid drying method at 170 °C. Results: The developed technological scheme enabled recovery of the target products from a single raw material. The DNA yield was 11.3% of the initial raw material mass. The final fraction contained 60–65% DNA, and the A260/A280 ratio ranged from 1.80 to 1.90, indicating relatively high purity. The yield of the hyaluronidase-containing fraction was 4.8% of the initial raw material mass on a dry-weight basis. Ultrafiltration increased specific activity of hyaluronidase-containing fraction 1.77-fold, from 1375 to 2437 IU/mg. Fourier-transform infrared spectroscopy confirmed the proteinaceous nature of the enzyme-containing preparation. Novelty of the Study: This study proposes an integrated technological scheme for fish milt processing that enables the sequential recovery of a hyaluronidase-containing fraction and a DNA fraction from a single raw material. The use of ultrafiltration as a concentration step increases enzyme activity without requiring expensive chromatographic purification, thereby improving the practical feasibility of the process. Conclusions: The proposed technology enables rational utilization of fish milt as a secondary biological raw material and allows recovery of biologically valuable DNA and a hyaluronidase-containing fraction within a single production cycle. The developed approach is technologically feasible and promising for further application in biotechnology, food processing, and pharmaceutical production.
No takes yet. Share an insight, caveat, or question.
Gerasimchik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: